Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESent-2
2022-502880-39-00Phase 2Completed
- Sponsor
- ApcinteX Ltd.
- Start
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 20
01
Overview
Phase 2, open-label, single-arm trial of serpinpc in hemophilia A and hemophilia B (HB), sponsored by ApcinteX Ltd. Started Jul 2023; status: completed.
02
Drugs
serpinpc
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on 2022-502880-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502880-39-00.